Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

SELL
$63.06 - $84.75 $706,902 - $950,047
-11,210 Reduced 1.38%
803,000 $57.6 Million
Q1 2022

May 04, 2022

BUY
$74.15 - $99.36 $2.31 Million - $3.1 Million
31,160 Added 3.98%
814,210 $65.9 Million
Q4 2021

Jan 13, 2022

SELL
$86.01 - $102.89 $18.7 Million - $22.4 Million
-217,575 Reduced 21.74%
783,050 $80.4 Million
Q3 2021

Oct 27, 2021

BUY
$84.7 - $96.31 $5.45 Million - $6.2 Million
64,345 Added 6.87%
1,000,625 $87.5 Million
Q2 2021

Jul 15, 2021

BUY
$76.44 - $89.57 $71.6 Million - $83.9 Million
936,280 New
936,280 $83.8 Million

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Vaughan Nelson Investment Management, L.P. Portfolio

Follow Vaughan Nelson Investment Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vaughan Nelson Investment Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Vaughan Nelson Investment Management, L.P. with notifications on news.